Literature DB >> 20206268

Therapeutic targeting of p53 by small molecules.

Galina Selivanova1.   

Abstract

Aberrant p53 function is one of the major requirements for tumor development. Reactivation of p53 function by small molecules is a promising strategy to combat cancer due to potent tumor suppressor activities of p53. Recent developments in p53 biology reveal that manipulation of p53 function might pave way to a long cancer-free life. A number of small molecules which rescue p53 function by different mechanisms, acting upstream of p53 or targeting the p53 protein itself have been identified. Notably, these molecules trigger different biological outcomes, suggesting that it might be feasible to direct p53-mediated response in a desired way. In this review I discuss the latest developments in the search for small molecules which rescue p53 function by targeting the p53 protein. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20206268     DOI: 10.1016/j.semcancer.2010.02.006

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  38 in total

1.  Restoration of DNA-binding and growth-suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway.

Authors:  Ricardo E Perez; Chad D Knights; Geetaram Sahu; Jason Catania; Vamsi K Kolukula; Daniel Stoler; Adolf Graessmann; Vasily Ogryzko; Michael Pishvaian; Christopher Albanese; Maria Laura Avantaggiati
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

2.  Effects of ginsenoside Rg2 on the ultraviolet B-induced DNA damage responses in HaCaT cells.

Authors:  Se Eun Ha; Dae Hyun Shin; Hyung Do Kim; Sun Mi Shim; Hack Soo Kim; Bo Hyeon Kim; Jung Sup Lee; Jong Kun Park
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-05-28       Impact factor: 3.000

3.  Chemopreventive effects of the p53-modulating agents CP-31398 and Prima-1 in tobacco carcinogen-induced lung tumorigenesis in A/J mice.

Authors:  Chinthalapally V Rao; Jagan Mohan R Patlolla; Li Qian; Yuting Zhang; Misty Brewer; Altaf Mohammed; Dhimant Desai; Shantu Amin; Stan Lightfoot; Levy Kopelovich
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

4.  Stabilization of mutant p53 via alkylation of cysteines and effects on DNA binding.

Authors:  Joel L Kaar; Nicolas Basse; Andreas C Joerger; Elaine Stephens; Trevor J Rutherford; Alan R Fersht
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

5.  p53 is positively regulated by miR-542-3p.

Authors:  Yemin Wang; Jen-Wei Huang; Maria Castella; David George Huntsman; Toshiyasu Taniguchi
Journal:  Cancer Res       Date:  2014-04-24       Impact factor: 12.701

6.  Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer.

Authors:  Joanna Zawacka-Pankau; Vera V Grinkevich; Sabine Hünten; Fedor Nikulenkov; Angela Gluch; Hai Li; Martin Enge; Alexander Kel; Galina Selivanova
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

7.  Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy.

Authors:  Ksenya Shchors; Anders I Persson; Fanya Rostker; Tarik Tihan; Natalya Lyubynska; Nan Li; Lamorna Brown Swigart; Mitchel S Berger; Douglas Hanahan; William A Weiss; Gerard I Evan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-29       Impact factor: 11.205

8.  Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.

Authors:  Wenwen Lu; Benita S Katzenellenbogen
Journal:  Horm Cancer       Date:  2017-06-02       Impact factor: 3.869

Review 9.  Contribution of p53 to metastasis.

Authors:  Emily Powell; David Piwnica-Worms; Helen Piwnica-Worms
Journal:  Cancer Discov       Date:  2014-03-21       Impact factor: 39.397

Review 10.  Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy.

Authors:  Miao Ding; Erlong Zhang; Rong He; Xingyong Wang
Journal:  Cancer Sci       Date:  2013-09-23       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.